Cephalon Compound definition

Cephalon Compound means any Cephalon Library Compound and any additional compound brought to the Collaboration by Cephalon.
Cephalon Compound means any compound **, which is ** at or after the **, and which is **.

Examples of Cephalon Compound in a sentence

  • Firms prequalified for work in this area may be requested to provide miscellaneous data collection services in support of various City programs or initiatives.

  • Either Party may terminate the Agreement at any time with respect to any Cephalon Compound, Development Compound or Licensed Product if, in that Party's sole judgment, such Cephalon Compound, Development Compound or Licensed Product is unsafe.

  • Within sixty (60) days of the Effective Date, Cephalon will commence the delivery of its Cephalon Compound Library on a schedule to be mutually agreed to by the Parties.

  • To the extent the non-terminating Party or a JV continues to develop or commercialize such Cephalon Compound, Development Compound or License Product, the non-terminating Party shall hold the terminating Party harmless from any and all liability, loss, damages, costs or expenses (including reasonable attorneys' fees) stemming from third party claims or actions based upon such continued development or commercialization.

  • If Sanofi-Synthelabo is the sole developer of a Cephalon Compound, then Net Sales of such Cephalon Compound in the Exclusive Territory shall be subject to a Discovery Royalty to Cephalon such that sum of the Transfer Price of the Cephalon Compound plus the Discovery Royalty equals [**] of Net Sales as provided under Section 6.5(a).

  • Any Party undertaking Sole Development of a Cephalon Compound shall do so at its sole discretion and risk, and, subject to Section 11.3, shall be responsible for all costs and expenses incurred in connection with such Sole Development.

  • If Cephalon is the sole developer of the Cephalon Compound, then Sanofi-Synthelabo shall have the first right to commercialize such Cephalon Compound in the Exclusive Territory by paying a development royalty of from [**] depending upon the Transfer Price of the Cephalon Compound, the sum of the Transfer Price, the Discovery Royalty and the Development Royalty being capped at [**].

  • For purposes of clarification, nothing in this Agreement shall be construed so as to preclude Cephalon from developing and commercializing outside the Field on a worldwide basis any Cephalon Compound that has not been designated as a Development Compound or a Backup Compound.

  • The terminating Party shall also forfeit all rights granted under this Agreement with respect to such Cephalon Compound, Development Compound or Licensed Product.

Related to Cephalon Compound

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Licensed Compound means [***].

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Compound means the taking of two or more ingredients and fabricating them into a single

  • Product Candidate means each of MYO-101, MYO-102, MYO-103, MYO-201 and MYO-301, as defined on Exhibit B, in each case in any form or formulation.

  • Collaboration Product means any pharmaceutical product in finished form that contains a Collaboration Compound, either as the sole active ingredient or in combination with one or more other active ingredients, and all present and future formulations, dosages and dosage forms thereof.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Compounds means a small molecule HMT inhibitor.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Licensed Product means any pharmaceutical product containing a Licensed Compound (alone or with other active ingredients), in all forms, presentations, formulations and dosage forms.

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • GSK has the meaning set forth in the preamble.

  • Commercialization or “Commercialize” means any and all activities undertaken at any time for a particular Licensed Product and that relate to the manufacturing, marketing, promoting, distributing, importing or exporting for sale, offering for sale, and selling of the Licensed Product, and interacting with Regulatory Authorities regarding the foregoing.

  • New Product means the Synology-branded hardware product and Synology-branded accessories contained in the original packaging Customer bought from an authorized Synology distributor or reseller. You may see our “New Product” at Product Support Status.

  • Biosimilar Product means, with respect to a Licensed Product in any country, any biosimilar product sold by a Third Party not authorized by or on behalf of Celgene, its Affiliates or Sublicensees, (a) that is a biosimilar biological product, as defined in 21 USC 379j-51 (or any successor or replacement thereof), a similar biological medicinal product, as defined in Annex I to Directive 2001/83/EC (or any successor or replacement thereof), or any similar biosimilar or generic product under the Laws of any country or jurisdiction, or (b) regarding which Regulatory Approval is obtained by referencing Regulatory Data of such Licensed Product.

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Covered Product The consumer product that You purchased concurrently with and is covered by this Agreement.

  • Companion Diagnostic means a device which is essential for the safe and effective use of a corresponding medicinal product to:

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Drug Product means a specific drug in dosage form from a known source of manufacture, whether